Compare MHH & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MHH | XTNT |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.5M | 82.6M |
| IPO Year | N/A | N/A |
| Metric | MHH | XTNT |
|---|---|---|
| Price | $7.40 | $0.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 34.4K | ★ 230.0K |
| Earning Date | 02-18-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $196,657,000.00 | $133,083,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | $4.50 | N/A |
| P/E Ratio | ★ N/A | $64.40 |
| Revenue Growth | 1.24 | ★ 16.88 |
| 52 Week Low | $6.20 | $0.34 |
| 52 Week High | $15.74 | $0.95 |
| Indicator | MHH | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 44.10 |
| Support Level | $6.44 | $0.70 |
| Resistance Level | $7.68 | $0.81 |
| Average True Range (ATR) | 0.43 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 68.32 | 3.78 |
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.